NYSEMKT: PTHS
Pelthos Therapeutics Inc Stock Ownership - Who owns Pelthos Therapeutics?

Insider buying vs selling

Have Pelthos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ezra M. FriedbergDirector2026-10-02558$20.72
$11.56kSell
Matthew PaulsDirector2026-10-02786$21.00
$16.51kSell
Peter GreenleafDirector2026-10-02797$21.17
$16.87kSell
Ezra M. FriedbergDirector2026-07-0224$27.33
$655.80Sell
Ezra M. FriedbergDirector2026-07-02534$26.03
$13.90kSell
Peter GreenleafDirector2026-07-02712$26.00
$18.51kSell
Peter GreenleafDirector2026-07-0285$27.27
$2.32kSell
Matthew PaulsDirector2026-07-02692$26.00
$17.99kSell
Matthew PaulsDirector2026-07-0294$27.36
$2.57kSell
Ezra M. FriedbergDirector2026-06-15224$27.13
$6.08kSell

1 of 3

PTHS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTHS insiders and whales buy or sell their stock.

PTHS Shareholders

What type of owners hold Pelthos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Todd C. Davis40.09%1,575,834$10.78MInsider
Ligand Pharmaceuticals Inc38.16%1,500,000$10.26MInsider
Motif Pharmaceuticals Ltd11.97%470,674$3.22MInsider
Boswell Prayer Ltd11.70%459,895$3.15MInsider
Aperture Healthcare Ventures Ltd10.85%426,566$2.92MInsider
Ame Equities LLC8.93%351,163$2.40MInsider
Ezra M. Friedberg8.26%324,628$2.22MInsider
Scott M. Plesha2.13%83,678$572.36kInsider
Knuettel Francis Ii1.04%40,841$279.35kInsider
Sai Rangarao0.78%30,518$208.74kInsider

1 of 3

PTHS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTHS0.03%99.97%Net BuyingNet Selling
PMN0.02%99.98%Net BuyingNet Buying
FLNA0.02%74.62%Net BuyingNet Buying
BCTX0.00%51.71%
NNVC0.00%100.00%

Pelthos Therapeutics Stock Ownership FAQ

Who owns Pelthos Therapeutics?

Pelthos Therapeutics (NYSEMKT: PTHS) is owned by 0.04% institutional shareholders, 137.14% Pelthos Therapeutics insiders, and 0.00% retail investors. Todd C. Davis is the largest individual Pelthos Therapeutics shareholder, owning 1.58M shares representing 40.09% of the company. Todd C. Davis's Pelthos Therapeutics shares are currently valued at $11.19M.

If you're new to stock investing, here's how to buy Pelthos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.